Genomics shed light on targeted treatment for myeloma
Updated POLLUX results for early relapsed myeloma patients
Are BCL2 and MCL1 inhibitors the key against myeloma?
MRD sequencing test approved for MM in the US
Targeting BCMA with bispecific antibodies in R/R myeloma